Table 1 Baseline patient characteristics
From: A prospective study examining cachexia predictors in patients with incurable cancer
Patient characteristics (n = 628) | ||
|---|---|---|
Median Age at inclusion (IQR) | 65 | (17) |
Gender f (%) | ||
Female | 359 | (57) |
Male | 269 | (43) |
Geographical region f (%) | ||
Europe | 578 | (92) |
Canada | 43 | (7) |
Australia | 7 | (1) |
Cancer type f (%) | ||
Low risk cancer | 184 | (29) |
Breast | 171 | (27) |
Haematological | 13 | (2) |
Neutral risk cancer | 410 | (65) |
Lung | 125 | (20) |
Colorectal | 70 | (11) |
Prostate | 48 | (8) |
Female genitalia | 36 | (6) |
Head and neck | 24 | (5) |
Urinary | 20 | (3) |
Hepatobiliary | 17 | (3) |
Sarcoma, connective and soft tissue | 17 | (3) |
Small intestine | 11 | (2) |
Oesophageal | 8 | (1) |
Other | 34 | (5) |
High risk cancer | 33 | (5) |
Pancreatic | 24 | (4) |
Gastric | 9 | (1) |
Cancer stage f (%) | ||
Local | 83 | (13) |
Metastatic/disseminated | 543 | (87) |
Treatment setting | ||
Inpatients | 56 | (9) |
Outpatients | 483 | (78) |
Home care | 77 | (13) |
Anti-cancer treatment | ||
Chemotherapy | 337 | (54) |
Hormonal therapy | 81 | (13) |
Radiotherapy | 35 | (6) |
Other | 47 | (7) |
No treatment | 173 | (28) |
Median Karnofsky PS (IQR) | 70 | (10) |
Weight loss (6 months) f (%) | ||
< 1% | 535 | (85) |
1–5% | 93 | (15) |
Mean BMI (SD) | 25.5 | (4.5) |
Comorbidities f (%) | ||
Heart disease | 165 | (26) |
COPD | 62 | (10) |
Arthritis | 51 | (8) |
Renal disease | 17 | (3) |